• Citer

Vascular disrupting activity of combretastatin analogues.

par Porcù, Elena;Salvador, Alessia;Primac, Irina ;Mitola, Stefania;Ronca, Roberto;Ravelli, Cosetta;Bortolozzi, Roberta;Vedaldi, Daniela;Romagnoli, Romeo;Basso, Giuseppe;Viola, Giampietro
Référence Vascular pharmacology, 83, page (78-89)
Publication Publié, 2016

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Vascular disrupting activity of combretastatin analogues.
Auteur:	Porcù, Elena; Salvador, Alessia; Primac, Irina; Mitola, Stefania; Ronca, Roberto; Ravelli, Cosetta; Bortolozzi, Roberta; Vedaldi, Daniela; Romagnoli, Romeo; Basso, Giuseppe; Viola, Giampietro
Informations sur la publication:	Vascular pharmacology, 83, page (78-89)
Statut de publication:	Publié, 2016
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Angiogenesis
	Combretastatin
	HUVEC
	Tubulin binding agents
	Vascular disrupting agents
MeSH keywords:	Angiogenesis Inducing Agents -- pharmacology
	Angiogenesis Inhibitors -- pharmacology
	Animals
	Antigens, CD -- metabolism
	Bibenzyls -- pharmacology
	Cadherins -- metabolism
	Capillary Permeability -- drug effects
	Cardiac Myosins -- metabolism
	Cell Line, Tumor
	Cell Movement -- drug effects
	Cell Proliferation -- drug effects
	Cell Shape -- drug effects
	Cells, Cultured
	Chick Embryo
	Chorioallantoic Membrane -- blood supply
	Dose-Response Relationship, Drug
	Focal Adhesion Kinase 1 -- metabolism
	Human Umbilical Vein Endothelial Cells -- drug effects -- metabolism
	Humans
	Melanoma, Experimental -- blood supply -- drug therapy -- pathology
	Mice, Inbred C57BL
	Myosin Light Chains -- metabolism
	Neovascularization, Pathologic
	Neovascularization, Physiologic -- drug effects
	Phosphorylation
	Signal Transduction -- drug effects
	Time Factors
Langue:	Anglais
Identificateurs:	urn:issn:1537-1891
	info:doi/10.1016/j.vph.2016.05.006
	info:pii/S1537-1891(15)30069-0
	info:pmid/27235861